About this study
The purpose of this study is to develop and maintain a registry database of all patients treated for a melanoma or a suspected metastatic lesion from a melanoma primary at MCF.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Patients with a melanoma or suspected melanoma metastasis who are treated surgically or non-surgically.
- Patients must be 18 years of age or older, with a maximum age of 99 years old.
- Patients enrolled prospectively must be capable of and willing to sign an informed consent.
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Sanjay Bagaria, M.D.
Open for enrollment